NIPT Beyond the Basics: Screening for Single-Gene Conditions

NIPT Beyond the Basics: Screening for Single-Gene Conditions

🎙 Kira Dineen, MS, LCGC, CG(ASCP)CM 👥 4K 📅 January 30, 2026 ⏱ 32 min 👁 197 📄 expert opinion 🧭 2026-08-16
Available in: English (current) Français

Keywords

NIPTsingle-gene disordersprenatal screeningultrasoundgenetic counseling

Summary

In this episode of DNA Today, host Kira Dineen, a certified genetic counselor, interviews Dr. Fred Ushakov, a fetal medicine expert from London, about the evolution of non-invasive prenatal testing (NIPT). They discuss the current landscape of NIPT in the UK, contrasting the public NHS combined screening approach with private clinics offering a range of tests. Dr. Ushakov highlights clinical limitations of traditional NIPT, including confusion due to many test names and a lack of awareness about rare genetic conditions beyond common trisomies. They introduce the SMART Test® strategy, which combines early anatomy scans at 10 weeks with NIPT to improve detection of structural anomalies and genetic conditions. The conversation focuses on the KNOVA test by Fulgent, which screens for 56 single-gene conditions associated with over 30 monogenic disorders. They explore which conditions may be detectable on ultrasound at various gestational ages, such as Noonan syndrome and skeletal dysplasias, and which are not, like Rett syndrome and CHARGE. The benefits of early knowledge are emphasized, including better pregnancy management and preparation for conditions like osteogenesis imperfecta. The episode underscores the importance of genetic counseling and informed consent, and notes that most single-gene conditions are de novo, making family history less relevant. The discussion concludes with insights into the future of prenatal screening innovation.

213 words

Critical Evaluation

Value of the Information & Strength of the Argument

The episode provides valuable insights into the practical application of expanded NIPT, particularly the integration of early ultrasound and genetic screening. Dr. Ushakov’s extensive clinical experience lends credibility to the discussion, and he offers concrete examples of conditions that may be missed by traditional screening. The argumentation is coherent, emphasizing the complementary roles of ultrasound and NIPT. However, the discussion is largely promotional for the KNOVA test, and the potential limitations or risks of expanded screening are not critically examined. The value lies in the expert perspective on clinical workflow and patient counseling, but the lack of balanced critique reduces the overall strength of the argumentation.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is moderate. The guest is a recognized expert, and the discussion is based on clinical experience, but no specific studies or data are cited. The sources provided in the description are relevant (London Pregnancy Clinic, Fulgent’s KNOVA, SMART Test) but are primarily commercial. The title accurately reflects the content, focusing on single-gene screening. The episode is sponsored by Fulgent, which is disclosed, but this may introduce bias. No comments were provided for analysis.

197 words

Title / Content Match

The title accurately reflects the content, which focuses on expanding NIPT to include single-gene conditions, as exemplified by the KNOVA test.

Quality & Reliability

7/10

The episode features a recognized fetal medicine expert with extensive clinical experience, and the discussion is grounded in practical knowledge. However, the content is largely opinion-based and promotional for a specific commercial product (KNOVA), with limited independent verification or balanced critique. The sponsor's involvement is disclosed but may introduce bias.

Key Moments

Cited Sources

  • London Pregnancy Clinic — Dr. Ushakov's clinic, mentioned as a resource for NIPT and ultrasound services.
  • Fulgent's KNOVA NIPT — The expanded NIPT test discussed in the episode, screening for 56 single-gene conditions.
  • The SMART Test® NIPT — A strategy combining early ultrasound and NIPT, developed by Dr. Ushakov's clinic.

Concurring Sources

Dissenting Sources

  • Critique of expanded NIPT panels — Some experts argue that expanded NIPT panels may increase false positives and anxiety without clear clinical benefit, a perspective not addressed in the episode.

Contribution & Novelties

This episode provides a practical perspective on the integration of expanded NIPT with early ultrasound, highlighting the clinical utility of screening for single-gene conditions. It offers insights into which conditions may be detectable on ultrasound and the benefits of early knowledge for pregnancy management. The discussion with a fetal medicine expert adds credibility and real-world experience.

Pour aller plus loin :

104 words

Radar Profile

The radar profile shows high scores in information quantity and quality, reflecting the expert discussion and practical insights. The technical level is moderate, suitable for a general audience. Reliability is moderate due to the promotional nature and lack of independent sources.

Reliability 7/10